BEGIN:VCALENDAR
PRODID:-//ics 70.9054//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP;TZID=Europe/Paris:20260419T111344
SUMMARY:MEETING : 2nd RNA'14 Therapeutics - Cancelled !
DTSTART;TZID=Europe/Paris:20171019T000000
DTEND;TZID=Europe/Paris:20171020T235959
UID:20171019191
DESCRIPTION:Meeting cancelled !
This meeting uses to explore new and in-depth developments currently being addressed in RNA therapies.
G. Pavlovic from PHENOMIN-ICS will orally present "The efficiency and simplicity of CRISPR/Cas9 technology to make precise changes to the genome of living cells has led to a new revolution in genetics"

CRISPR/Cas9 genome editing opens new possibilities for modelling human disease in rodents like easy generation of structural variant models and large humanisation of large locus in mouse
Scientists are concerned by CRISPR/Cas9 mediated off-targets but other CRISPR drawbacks are poorly evaluated
Especially, careful characterisation of mouse and rat generated by CRISPR/Cas9 show unexpected mutations like concatemers, ssODN random integration or chromosomal rearrangements
Finally, we will discuss how rodents can be used to evaluate safety of CRISPR/Cas9 therapeutic approaches especially for unexpected genome modifications

 
LOCATION:Barcelona, Spain
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR